Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Flexi Cap Fund median (46 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 07 Sep 2022 – 20 Aug 2026, limited by Sundaram Flexicap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Sundaram Flexicap Fund | Nifty 500 |
|---|---|---|
| 07 Sep 2022 | ₹100.00 | ₹100.00 |
| 05 Jan 2023 | ₹100.49 | ₹100.44 |
| 06 May 2023 | ₹101.02 | ₹99.73 |
| 03 Sep 2023 | ₹113.90 | ₹111.46 |
| 01 Jan 2024 | ₹127.32 | ₹126.83 |
| 30 Apr 2024 | ₹133.66 | ₹137.06 |
| 29 Aug 2024 | ₹151.15 | ₹154.26 |
| 27 Dec 2024 | ₹148.39 | ₹146.51 |
| 26 Apr 2025 | ₹145.22 | ₹142.62 |
| 24 Aug 2025 | ₹156.29 | ₹150.08 |
| 23 Dec 2025 | ₹161.07 | ₹155.98 |
| 22 Apr 2026 | ₹154.35 | ₹150.08 |
| 20 Aug 2026 | ₹154.44 | ₹153.48 |
| Metric | Sundaram · Direct NAV ₹15.46 Very High risk ★★☆☆☆ | Category median Flexi Cap Fund · 46 funds |
|---|---|---|
| -1.68% | +4.32% | |
| +11.40% | +14.11% | |
| — | +12.53% | |
| — | +13.78% | |
| +11.63% | +14.48% | |
| +8.99% | — | |
| +14.67% | +16.56% | |
| — | +15.80% | |
| — | +15.46% | |
| Risk | ||
| 13.17% | 14.19% | |
| 0.37 | 0.53 | |
| 0.51 | 0.73 | |
| -15.66% | -30.01% | |
| Nifty 500 | — | |
| -0.14% | +2.15% | |
| 0.91 | 0.97 | |
| 91.0% | 102.4% | |
| 88.3% | 90.2% | |
| 0.85% | 0.96% | |
| ₹1,976Cr | ₹4,325Cr | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | 34% | |
| — | — | |
| 07 Sep 2022 | — | |
| — | — | |
| — | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.